Agilent provides xCELLigence impedance-based, label-free, real time cell analysis system and NovoCyte flow cytometers.
Discover
Back to filter
Show all topics (10)
Related topics
SARS-CoV-2 N Protein Antigen Test as new Quanterix tool in ultrasensitive biomarkers detection
Apr 12, 2021
Digital health solution, Simoa, is changing the way in which the biology of health and disease is studied by giving...
Observe the movement of live cells that make up living tissue in vivo!
Apr 12, 2021
IntraVital Microscopy is a technique that enables you to directly observe the movement of live cells that make up...
Single-cell DNA Analysis of a Novel Acute Erythroid Leukemia CRISPR Induced Mouse Model
Apr 12, 2021
Single-cell DNA Analysis of a Novel Acute Erythroid Leukemia (AEL) CRISPR Induced Mouse Model.
Assessment of...
Developing tools for multiplex to single EV analysis pipelines
Apr 12, 2021
Extracellular vesicles (EVs) are lipid spheres released from cells. EVs express proteins...
SARS-CoV-2 detection workflow in wastewater- Analytik Jena and project in Japan
Apr 12, 2021
In 2020 Analytik Jenas real-time PCR thermal cyclers of the qTOWER³ series even supported one of the first SARS-CoV-2...
Mar 31, 2021
Cancer cells exhibit metabolic...
Cytek webinar : Improved flow cytometry assay resolution with autofluorescence extraction
Mar 30, 2021
The power of autofluorescence extraction in the detection of dim fluorescence on highly...
Innovation never takes a break with IncuCyte
Mar 11, 2021
Analyze your cells for days, weeks or even months as they sit stationary in the stable...
Curiox webinar - how to retain more cells for Single Cell Sequencing and proteogenomics ?
Feb 15, 2021
Curiox Laminar Wash technology has been added as part of the official BioLegend TotalSeq...
Cytek Aurora in Action : how to easily resolve highly overlapping dyes ?
Feb 2, 2021
Learn from Jeff Nelson, a manager of a cytometry shared resource laboratory, about the...
Differentation displacement in acute myeloid leukemia through enhancer activation
Aug 7, 2018
LSD1 is a flavin adenine dinucleotide (FAD)-dependent homolog of the amine oxidase family and there was recently brought attention to it as a potential therapeutic target. The interest came from an observation of unusually high expression of LSD1 in certain types of poor-prognosis cancers. It was previously thought that LSD1 removes monomethyl and dymethyl histone marks. However, recently it was showed that it interacts with multiple transcripton factor. This raised a possibility of other drugs being used.
New inhibitor ORY-1001 was succesfully tested on LSD1 and blast cell differentioation was observed. The flow cytometric testing on this experiment was done with Novocyte. ORY-1001 disrupts the protein interaction between LSD1 and GFI1.
Related technologies: Conventional flow cytometry
Brand profile
